SprintRay owner Xunshi Technology sues Shining3D in US federal court over five dental 3D-printing patents
Hardware
Originally reported by 3D打印资源库
Xunshi Technology, parent of digital-dental 3D printing brand SprintRay, has filed a patent infringement suit against Shining3D and its US affiliate in the US District Court for the Northern District of California, case number 4:26-cv-06026. The complaint alleges infringement of five US patents covering resin-curing substrate design, reservoir and substrate assembly architecture, and print separation-force control in vat photopolymerization systems. Named products include Shining3D's AccuFab-F1 and AccuFab-CEL desktop 3D printers along with their companion resin-vat components, both sold through Shining3D's official website and US retail channels. The case is at an early procedural stage and Shining3D has not issued a public response.
The dispute lands squarely in chairside and lab-based dental vat photopolymerization, a segment where qualification cycles are faster than aerospace but where FDA 510(k) clearance still anchors product credibility, and where SprintRay and Shining3D compete directly for US dental practice and lab customers alongside Formlabs. Separation-force control is a mechanically specific claim area: it governs how a cured layer releases from the build platform without tearing, a detail that sits inside the printer's core mechanism rather than its marketing surface. That makes this a case of narrow technical IP potentially embedded deep in product architecture, the kind of dispute that tends to matter more once claim construction narrows the actual scope of what's protected. It also reflects a broader pattern of Chinese AM suppliers moving from domestic scale to direct US retail presence, which raises the odds of running into incumbents' patent portfolios head-on.
At the complaint stage, there is no injunction and no finding of infringement, so Shining3D's AccuFab-F1 and AccuFab-CEL remain on sale in the US for now. Current US buyers of these two printers don't need to change purchasing plans yet, but Shining3D will need to either contest the specific separation-force and substrate claims on their technical merits or work out a licensing resolution before this reaches a point where product availability is at risk.
Topics